跳至主要内容
临床试验/DRKS00029137
DRKS00029137已完成未知

Visual function, optical disturbance, spectacle independence and patient satisfaction after implantation of trifocal intraocular lens (Acrysof IQ PanOptix) in cataract patients: unilateral versus bilateral implantation.

MVZ RHR Augenärzte GmbH Düsseldorf0 个研究点目标入组 72 人开始时间: 2022年7月5日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
入组人数
72

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Non-randomized controlled study
盲法
Open (masking not used)

入排标准

年龄范围
50 Years 至 81 Years(—)
性别
All

入选标准

  • 1. Patients with cataract in both eyes and with a medical indication of a cataract extraction with an implantation of an artificial lens. All the patients have voluntarily and independent from the study decided for a unilateral or bilateral implantation of a trifocal Acrysof IQ PanOptix lens, after a medical enlightenment talk with the treated ophthalmologist. Only capable of consent adults will be included in the study.
  • 2. Age 50-81.
  • 3. No other eye disease.
  • 4. No refractive operation in the patient history.
  • 5. No secondary cataract or already treated secondary cataract with YAG-Laser Kapsulotomy by the time of the evaluation 3 months after the second operation.

排除标准

  • 1. Missing patient consent
  • 2. Presence of other eye diseases
  • 3. Postoperative complications that affect the visual aquity
  • 4. Necessity for a re-operation
  • 5. No appearance for the postoperativ evaluation (follow-up).

研究者

发起方
MVZ RHR Augenärzte GmbH Düsseldorf

相似试验